Fortress Biotech to Participate in Four March 2021 Virtual Investor Conferences

    NEXT STORY
    Sunshine Biopharma Receives Recently Ordered New Batch of Adva-27a and Initiates QA/QC Testing
    PREV STORY
    Psyence Group Launches its Functional Mushroom Brand, “Goodmind”
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Sanofi : FDA approves Libtayo® (cemiplimab) as first and only treatment for advanced cutaneous squamous cell carcinoma

    FDA approves Libtayo® (cemiplimab-rwlc) as first and only treatment for advanced cutaneous squamous cell ...

    author_avatar
    NASDAQ Market News

    InspireMD Announces the European Society of Cardiology 2020 “Best Poster Award” for Updated Data from the PARADIGM-EXTEND Study

    author_avatar
    NASDAQ Market News

    Trillium Therapeutics Appoints Michael Kamarck, Ph.D., to Its Board of Directors

    author_avatar
    NASDAQ Market News